In Reply.—We never conceived our letter to the editor as a formal epidemiologic study.1 Instead, we were sending a dispatch from the front lines of autopsy work during the early weeks of the coronavirus disease (COVID-19) pandemic. We do not consider exposure in the general population equivalent to exposure in morgue workers during an autopsy; we were simply providing a simple comparison to help readers understand that the risk of a properly protected morgue worker contracting COVID-19 from autopsy is slight. We agree with the authors that autopsy is an essential component of understanding this new disease. We continue to advocate for the value of autopsy in elucidating the pathobiology of COVID-19, ensuring accurate public health information for managing the pandemic, and procuring and preserving important specimens for research to learn more about COVID-19. The only way to realize these 3 benefits of autopsy is to perform autopsies. We wrote our letter to reduce confusion in a time of uncertainty and to encourage appropriately cautious autopsy pathologists to engage in their important work on patients who died with COVID-19 infection—provided that the pathologists and their staff have the necessary facility, equipment, supervision, and experience to safely and effectively conduct such autopsies. The pathologists involved in this autopsy work at academic centers should include residents in training.2 As tomorrow's pathologists will be expected to help manage the next infectious disease pandemic, it is imperative that today's pathology residents engage in all aspects of their institution's response to COVID-19, including participating in the performance of autopsies when they are conducted.
Skip Nav Destination
Article navigation
letter|
September 15 2020
In Reply
Gregory G. Davis, MD, MSPH;
Gregory G. Davis, MD, MSPH
1Forensic Division, Department of Pathology, University of Alabama at Birmingham
2Jefferson County Coroner/Medical Examiner Office, Birmingham, Alabama
Search for other works by this author on:
Alex K. Williamson, MD
Alex K. Williamson, MD
3Department of Pathology & Laboratory Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York
4Department of Pathology, LIJ Medical Center/Northwell, New Hyde Park, New York
Search for other works by this author on:
Arch Pathol Lab Med (2021) 145 (1): 7b–8.
Article history
Accepted:
August 31 2020
Citation
Gregory G. Davis, Alex K. Williamson; In Reply. Arch Pathol Lab Med 1 January 2021; 145 (1): 7b–8. doi: https://doi.org/10.5858/arpa.2020-0575-LE
Download citation file:
Sponsored Video
1,418
Views
0
Citations
Citing articles via
Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor
Bokyung Ahn, MD, PhD, Joo Young Kim, MD, PhD, Seung-Mo Hong, MD, PhD
Emerging Immunohistochemical Biomarkers for Myeloid Neoplasms
Anuj Verma, MBBS, MD, Mina L. Xu, MD
Intraoperative Lymph Node Assessment (Touch Preparation Only) for Metastatic Breast Carcinoma in Neoadjuvant and Non-neoadjuvant Settings
Esma Ersoy, MD, Mahmoud Elsayad, MD, Madhavi Pandiri, MD, Alexander Knee, MS, Q. Jackie Cao, MD, PhD, Giovanna M. Crisi, MD, PhD
Biopsy-Integrated 3D Magnetic Resonance Imaging Modeling of Prostate Cancer and Its Application for Gleason Grade and Tumor Laterality Assessment
Jisup Kim, MD, Bumjin Lim, MD, In Gab Jeong, MD, PhD, Jae Y. Ro, MD, PhD, Heounjeong Go, MD, PhD, Yong Mee Cho, MD, PhD, Kye Jin Park, MD
An Appraisal of Immunohistochemical Stain Use in Hepatic Metastasis Highlights the Effectiveness of the Individualized, Case-Based Approach: Analysis of Data From a Tertiary Care Medical Center
Jeff D. Wang, MD, Christopher Sebastian, MD, Zenta Walther, MD, PhD, Tejas Suresh, MD, Jill Lacy, MD, Xuchen Zhang, MD, PhD, Dhanpat Jain, MD
Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services
Glenn Ramsey, MD, Yara A. Park, MD, Anne F. Eder, MD, PhD, Aleh Bobr, MD, Matthew S. Karafin, MD, MS, Julie K. Karp, MD, Karen E. King, MD, Monica B. Pagano, MD, Joseph Schwartz, MD, MPH, Zbigniew M. Szczepiorkowski, MD, PhD, Rhona J. Souers;, MS, Lamont Thomas, MT(ASCP), Meghan Delaney, DO, MPH
Verrucous Squamous Hyperplasia of the Urinary Bladder: A Series of 23 Cases
Daniel H. Russell, MD, Russell Vang, MD, Jonathan I. Epstein, MD
Reducing Laboratory Turnaround Time in Patients With Acute Stroke and the Lack of Impact on Time to Reperfusion Therapy
Sasipong Trongnit, MD, Kanit Reesukumal, MD, Gerald J. Kost, MD, PhD, Yongchai Nilanont, MD, Busadee Pratumvinit, MD
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus
Alejandro A. Gru, MD, Megan S. Lim, MD, PhD, Ahmet Dogan, MD, PhD, Steven M. Horwitz, MD, Jan Delabie, MD, PhD, Kai Fu, MD, PhD, Deniz Peker, MD, Vishnu V. B. Reddy, MD, Mina L. Xu, MD, Kiran Vij, MD, Graham W. Slack, MD, Roberto N. Miranda, MD, Deepa Jagadeesh, MD, Julie M. Lisano, PharmD, Eric D. Hsi, MD, Emina Torlakovic, MD, PhD